表紙
市場調查報告書

採血針的全球市場 至2024年的預測:安全採血針 (按鈕式、壓力操作式、側面按鈕式),個人採血針

Lancets Market by Type (Safety Lancets (Push button, Pressure Activated, Side Button), Personal Lancets), Application (Glucose Testing, Hemoglobin Testing), End User (Hospital, Clinic, Homecare), Region - Global Forecast to 2024

出版商 MarketsandMarkets 商品編碼 871389
出版日期 內容資訊 英文 108 Pages
訂單完成後即時交付
價格
採血針的全球市場 至2024年的預測:安全採血針 (按鈕式、壓力操作式、側面按鈕式),個人採血針 Lancets Market by Type (Safety Lancets (Push button, Pressure Activated, Side Button), Personal Lancets), Application (Glucose Testing, Hemoglobin Testing), End User (Hospital, Clinic, Homecare), Region - Global Forecast to 2024
出版日期: 2019年06月17日內容資訊: 英文 108 Pages
簡介

全球採血針市場規模預測將從2019年的128億美元到2024年達到170億美元的規模,並以5.8%的年複合成長率 (CAGR) 成長。該市場的成長主要是重要的用途中對堅固的採血針的需求擴大,基礎設施相關開發的擴大,及PVC材料需求的增加等所促進。可是,採血針的技術性訣竅不足抑制著市場成長。

本報告提供全球採血針市場相關調查,提供市場概要,各媒體、材料、產業、地區的市場分析,競爭情形及主要企業的簡介等系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 採血針市場概要
  • 北美的採血針市場:各類型
  • 歐洲的採血針市場:各類型
  • 採血針市場:地區概述

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進要素
    • 阻礙要素
    • 機會
    • 課題

第6章 採血針市場:各類型

  • 簡介
  • 安全採血針
    • 按鈕式
    • 壓力操作式
    • 側面按鈕式
  • 個人採血針

第7章 採血針市場:各用途

  • 簡介
  • 葡萄糖試驗
  • 血紅素試驗
  • 凝固試驗
  • 其他的用途

第8章 採血針市場:各終端用戶

  • 簡介
  • 醫院、診所
  • 居家醫療
  • 其他終端用戶

第9章 採血針市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他 (ROW)

第10章 競爭情形

  • 簡介
  • 競爭領導製圖

第11章 企業簡介

  • BECTON, DICKINSON AND COMPANY
  • ROCHE DIAGNOSTICS
  • YPSOMED
  • B. BRAUN MELSUNGEN
  • Terumo Corporation
  • OWEN MUMFORD
  • HTL-STREFA S.A
  • ARKRAY
  • SARSTEDT
  • STERILANCE MEDICAL (SUZHOU)
  • MEDLINE INDUSTRIES
  • INTRINSYK

第12章 附錄

目錄
Product Code: MD 7166

"The lancets market is projected to grow at a CAGR of 12.4% during the forecast period (2019-2024)."

The lancets market is projected to reach USD 1,442 million by 2024 from USD 804 million in 2019, at a CAGR of 12.4%. Market growth is attributed to the growing prevalence of diabetes and the high prevalence of infectious diseases. However, the risk of needlestick injuries and the poor reimbursement scenario in developing countries may restrain market growth.

"By type, the safety lancets segment is expected to grow at the highest CAGR during the forecast period."

Based on type, the lancets market is segmented into safety and personal lancets. The safety lancets segment is expected to grow at the highest CAGR during the forecast period. This is mainly due to the benefits associated with safety lancets such as their ease of use, the capability to prevent needlestick injuries and cross-contamination, and painlessness of vein puncture.

"By end user, the hospitals and clinics segment to dominate the lancets market in 2019."

On the basis of end user, the lancets market is segmented into hospitals and clinics, home care settings, and other end users. The hospitals and clinics segment is expected to hold the largest share of the lancets market in 2019. This is attributed to rising awareness about diabetes treatment and the increasing prevalence of infectious diseases that require blood testing.

"APAC is expected to witness the highest growth during the forecast period."

North America is expected to account for the largest share of the lancets market in 2019, followed by Europe. The large share of the market in North America can majorly be attributed to the increasing prevalence of diabetes and the favorable reimbursement scenario in the region. However, the APAC region is expected to witness the highest CAGR during the forecast period. This can primarily be attributed to the growing healthcare industry, increasing geriatric population, rapid economic growth, and rising awareness about diabetes treatment.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-55%, Tier 2-25%, and Tier 3-20%
  • By Designation: C-level-43%, Director-level-32%, and Others-25%
  • By Region: North America-38%, Europe-23%, Asia Pacific-29%, Rest of the World-10%

The prominent players in the lancets market are: Becton, Dickinson and Company (US), Roche Diagnostics (Switzerland), Ypsomed (Switzerland), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Own Mumford (UK), HTL-STREFA S.A (Poland), ARKRAY (Japan), Sarstedt (Germany), and SteriLance Medical (Suzhou) (China).

Research Coverage:

The report analyzes the lancets market and aims at estimating the market size and future growth potential of the lancets and the different segments by type, application, and end user. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the lancets market
  • Product & Service Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product or service launches in the lancets market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products and services, growing geographies, and recent developments in the global lancets market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products & services of the leading players in the lancets market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.3. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. LANCETS MARKET OVERVIEW
  • 4.2. NORTH AMERICA: LANCETS MARKET, BY TYPE, 2018
  • 4.3. EUROPE: LANCETS MARKET, BY TYPE, 2018
  • 4.4. LANCETS MARKET: GEOGRAPHIC SNAPSHOT

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Growing prevalence of diabetes
      • 5.2.1.2. High prevalence of infectious diseases
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Risk of needlestick injuries
      • 5.2.2.2. Poor reimbursement scenario in developing countries
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. High growth prospects in emerging countries
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Reuse of lancets

6. LANCETS MARKET, BY TYPE

  • 6.1. INTRODUCTION
  • 6.2. SAFETY LANCETS
    • 6.2.1. PUSH-BUTTON LANCETS
      • 6.2.1.1. Ease of use and simplicity have driven demand for push-button lancets
    • 6.2.2. PRESSURE-ACTIVATED LANCETS
      • 6.2.2.1. These lancets are available in a number of gauge sizes and penetration depths
    • 6.2.3. SIDE-BUTTON LANCETS
      • 6.2.3.1. Ease of use and anti-reuse measures have made side-button lancets popular among end users
  • 6.3. PERSONAL LANCETS
    • 6.3.1. INCREASING PREVALENCE OF DIABETES HAS RESULTED IN SIGNIFICANT DEMAND FOR PERSONAL LANCETS

7. LANCETS MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. GLUCOSE TESTING
    • 7.2.1. INCREASING DIABETES PREVALENCE IS EXPECTED TO DRIVE THE DEMAND FOR LANCETS IN GLUCOSE TESTING DURING THE FORECAST PERIOD
  • 7.3. HEMOGLOBIN TESTING
    • 7.3.1. HIGH PREVALENCE OF ANEMIA EXPECTED TO INCREASE HEMOGLOBIN TESTING VOLUME AND THE DEMAND FOR LANCETS
  • 7.4. COAGULATION TESTING
    • 7.4.1. RISING PREVALENCE OF LIVER DISEASES, THROMBOPHILIA, AND HEMOPHILIA TO DRIVE THE DEMAND FOR COAGULATION TESTING
  • 7.5. OTHER APPLICATIONS
    • 7.5.1. THIS SEGMENT COVERS OTHER APPLICATIONS OF LANCETS, SUCH AS PREGNANCY TESTING, INFECTIOUS DISEASES TESTING, AND CHOLESTEROL TESTING.

8. LANCETS MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. HOSPITALS & CLINICS
    • 8.2.1. INCREASING INCIDENCE OF DISEASES THAT REQUIRE BLOOD TESTING FOR DIAGNOSIS AND TREATMENT IS DRIVING THE ADOPTION OF LANCETS IN HOSPITALS AND CLINICS
  • 8.3. HOME CARE SETTINGS
    • 8.3.1. INCREASING PREVALENCE OF DIABETES IS EXPECTED TO DRIVE THE DEMAND FOR LANCETS IN THE HOME CARE SETTINGS SEGMENT DURING THE FORECAST PERIOD
  • 8.4. OTHER END USERS

9. LANCETS MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. HIGH DIABETIC POPULATION AND REIMBURSEMENT COVERAGE FOR LANCETS WILL DRIVE MARKET GROWTH IN NORTH AMERICA
  • 9.3. EUROPE
    • 9.3.1. RISING AWARENESS ON DIABETES TREATMENT AND PREVENTION WILL CONTRIBUTE TO LANCET USE IN EUROPE
  • 9.4. ASIA PACIFIC
    • 9.4.1. RAPID ECONOMIC GROWTH IN APAC COUNTRIES WILL PROVIDE OPPORTUNITIES FOR MARKET PLAYERS
  • 9.5. ROW

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. COMPETITIVE LEADERSHIP MAPPING (2018)
    • 10.2.1. VENDOR INCLUSION CRITERIA
    • 10.2.2. VISIONARY LEADERS
    • 10.2.3. INNOVATORS
    • 10.2.4. DYNAMIC DIFFERENTIATORS
    • 10.2.5. EMERGING COMPANIES

11. COMPANY PROFILES (Business Overview, Products Offered, Recent Developments, MnM View)*

  • 11.1. BECTON, DICKINSON AND COMPANY
  • 11.2. ROCHE DIAGNOSTICS
  • 11.3. YPSOMED
  • 11.4. B. BRAUN MELSUNGEN
  • 11.5. TERUMO CORPORATION
  • 11.6. OWEN MUMFORD
  • 11.7. HTL-STREFA S.A
  • 11.8. ARKRAY
  • 11.9. SARSTEDT
  • 11.10. STERILANCE MEDICAL (SUZHOU)
  • 11.11. MEDLINE INDUSTRIES
  • 11.12. INTRINSYK

*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. DISCUSSION GUIDE
  • 12.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3. AVAILABLE CUSTOMIZATIONS
  • 12.4. RELATED REPORTS
  • 12.5. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: INCIDENCE OF INFECTIOUS DISEASES
  • TABLE 2: LANCETS MARKET, BY TYPE, 2017-2024 (USD BILLION)
  • TABLE 3: SAFETY LANCETS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 4: SAFETY LANCETS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 5: PUSH-BUTTON LANCETS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 6: PRESSURE-ACTIVATED LANCETS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 7: SIDE-BUTTON LANCETS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 8: PERSONAL LANCETS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 9: LANCETS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 10: LANCETS MARKET FOR GLUCOSE TESTING, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11: LANCETS MARKET FOR HEMOGLOBIN TESTING, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 12: LANCETS MARKET FOR COAGULATION TESTING, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 13: LANCETS MARKET FOR OTHER APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 14: LANCETS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 15: LANCETS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 16: LANCETS MARKET FOR HOME CARE SETTINGS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 17: LANCETS MARKET FOR OTHER END USERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 18: LANCETS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 19: NORTH AMERICA: LANCETS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 20: NORTH AMERICA: SAFETY LANCETS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 21: NORTH AMERICA: LANCETS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 22: NORTH AMERICA: LANCETS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 23: EUROPE: LANCETS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 24: EUROPE: SAFETY LANCETS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 25: EUROPE: LANCETS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 26: EUROPE: LANCETS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 27: APAC: LANCETS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 28: APAC: LANCETS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 29: APAC: SAFETY LANCETS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 30: APAC: LANCETS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 31: APAC: LANCETS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 32: CHINA: LANCETS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 33: CHINA: SAFETY LANCETS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 34: CHINA: LANCETS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 35: CHINA: LANCETS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 36: AUSTRALIA: LANCETS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 37: AUSTRALIA: SAFETY LANCETS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 38: AUSTRALIA: LANCETS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 39: AUSTRALIA: LANCETS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 40: SOUTH KOREA: LANCETS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 41: SOUTH KOREA: SAFETY LANCETS MARKET, BY TYPE, 2017-2024 (USD THOUSAND)
  • TABLE 42: SOUTH KOREA: LANCETS MARKET, BY APPLICATION, 2017-2024 (USD THOUSAND)
  • TABLE 43: SOUTH KOREA: LANCETS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 44: INDONESIA: LANCETS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 45: INDONESIA: SAFETY LANCETS MARKET, BY TYPE, 2017-2024 (USD THOUSAND)
  • TABLE 46: INDONESIA: LANCETS MARKET, BY APPLICATION, 2017-2024 (USD THOUSAND)
  • TABLE 47: INDONESIA: LANCETS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 48: MALAYSIA: LANCETS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 49: MALAYSIA: SAFETY LANCETS MARKET, BY TYPE, 2017-2024 (USD THOUSAND)
  • TABLE 50: MALAYSIA: LANCETS MARKET, BY APPLICATION, 2017-2024 (USD THOUSAND)
  • TABLE 51: MALAYSIA: LANCETS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 52: THAILAND: LANCETS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 53: THAILAND: SAFETY LANCETS MARKET, BY TYPE, 2017-2024 (USD THOUSAND)
  • TABLE 54: THAILAND: LANCETS MARKET, BY APPLICATION, 2017-2024 (USD THOUSAND)
  • TABLE 55: THAILAND: LANCETS MARKET, BY END USER, 2017-2024 (USD THOUSAND)
  • TABLE 56: VIETNAM: LANCETS MARKET, BY TYPE, 2017-2024 (USD THOUSAND)
  • TABLE 57: VIETNAM: SAFETY LANCETS MARKET, BY TYPE, 2017-2024 (USD THOUSAND)
  • TABLE 58: VIETNAM: LANCETS MARKET, BY APPLICATION, 2017-2024 (USD THOUSAND)
  • TABLE 59: VIETNAM: LANCETS MARKET, BY END USER, 2017-2024 (USD THOUSAND)
  • TABLE 60: SINGAPORE: LANCETS MARKET, BY TYPE, 2017-2024 (USD THOUSAND)
  • TABLE 61: SINGAPORE: SAFETY LANCETS MARKET, BY TYPE, 2017-2024 (USD THOUSAND)
  • TABLE 62: SINGAPORE: LANCETS MARKET, BY APPLICATION, 2017-2024 (USD THOUSAND)
  • TABLE 63: SINGAPORE: LANCETS MARKET, BY END USER, 2017-2024 (USD THOUSAND)
  • TABLE 64: NEW ZEALAND: LANCETS MARKET, BY TYPE, 2017-2024 (USD THOUSAND)
  • TABLE 65: NEW ZEALAND: SAFETY LANCETS MARKET, BY TYPE, 2017-2024 (USD THOUSAND)
  • TABLE 66: NEW ZEALAND: LANCETS MARKET, BY APPLICATION, 2017-2024 (USD THOUSAND)
  • TABLE 67: NEW ZEALAND: LANCETS MARKET, BY END USER, 2017-2024 (USD THOUSAND)
  • TABLE 68: ROAPAC: LANCETS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 69: ROAPAC: SAFETY LANCETS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 70: ROAPAC: LANCETS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 71: ROAPAC: LANCETS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 72: ROW: LANCETS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 73: ROW: SAFETY LANCETS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 74: ROW: LANCETS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 75: ROW: LANCETS MARKET, BY END USER, 2017-2024 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: LANCETS MARKET
  • FIGURE 2: LANCETS MARKET: RESEARCH METHODOLOGY
  • FIGURE 3: RESEARCH DESIGN
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 6: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: LANCETS MARKET, BY TYPE, 2019-2024
  • FIGURE 9: LANCETS MARKET, BY APPLICATION, 2019
  • FIGURE 10: LANCETS MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
  • FIGURE 11: GEOGRAPHICAL SNAPSHOT OF THE LANCETS MARKET
  • FIGURE 12: INCREASING INCIDENCE DIABETES TO DRIVE THE GROWTH OF THE LANCETS MARKET
  • FIGURE 13: SAFETY LANCETS HELD LARGEST SHARE OF THE NORTH AMERICAN MARKET, 2018
  • FIGURE 14: PUSH-BUTTON LANCETS TO DOMINATE THE EUROPEAN MARKET DURING THE FORECAST PERIOD
  • FIGURE 15: ASIA PACIFIC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 16: LANCETS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
  • FIGURE 17: SAFETY LANCETS TO WITNESS THE HIGHEST GROWTH IN THE LANCETS MARKET FROM 2019 TO 2024
  • FIGURE 18: GLUCOSE TESTING WAS THE LARGEST APPLICATION SEGMENT IN THE LANCETS MARKET IN 2018
  • FIGURE 19: LANCETS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
  • FIGURE 20: NORTH AMERICA: LANCETS MARKET SNAPSHOT
  • FIGURE 21: ASIA PACIFIC: LANCETS MARKET SNAPSHOT
  • FIGURE 22: MNM DIVE-VENDOR COMPARISON MATRIX: LANCETS MARKET
  • FIGURE 23: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 24: ROCHE DIAGNOSTICS: COMPANY SNAPSHOT
  • FIGURE 25: YPSOMED: COMPANY SNAPSHOT
  • FIGURE 26: B.BRAUN: COMPANY SNAPSHOT
  • FIGURE 27: TERUMO CORPORATION: COMPANY SNAPSHOT